Vivos (RDGL) Research & Development (2017 - 2025)
Vivos (RDGL) posted Research & Development of $57,166 for Q4 2025, down 43.4% from $100,969 a year earlier and down 15.7% from the prior quarter.
Analysis
Vivos (RDGL) Research & Development (2017 - 2025) Analysis & Trends
For FY2025, Vivos' Research & Development came in at $352,232, up 8.5% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 33.0% (FY2020 to FY2025).
- In prior years, Vivos' Research & Development was $324,629 in FY2024 (-55.7%), $732,698 in FY2023 (+113.1%), $343,802 in FY2022 (+19.9%) and $286,848 in FY2021 (+238.8%).
- The Q4 2025 figure stands as the lowest quarterly Research & Development since Q1 2023.
- On a year-over-year basis, Research & Development increased in four of the last eight quarters, with an average decline of 4.8%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2021, with growth of 440.5%; the weakest was Q4 2024, with a decline of 76.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $67,820 (Q3 2025), $107,965 (Q2 2025) and $119,281 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 258.00 Mn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 278.90 Mn |
| 10 | Vivos | 22.77 Mn | 13.09 Mn | -3,105.00 | 57,166.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 57,166.00 |
| Sep 30, 2025 | 67,820.00 |
| Jun 30, 2025 | 107,965.00 |
| Mar 31, 2025 | 119,281.00 |
| Dec 31, 2024 | 100,969.00 |
| Sep 30, 2024 | 66,551.00 |
| Jun 30, 2024 | 99,662.00 |
| Mar 31, 2024 | 57,447.00 |
| Dec 31, 2023 | 432,112.00 |
| Sep 30, 2023 | 80,858.00 |
| Jun 30, 2023 | 173,353.00 |
| Mar 31, 2023 | 46,375.00 |
| Dec 31, 2022 | 31,736.00 |
| Sep 30, 2022 | 70,765.00 |
| Jun 30, 2022 | 169,732.00 |
| Mar 31, 2022 | 72,569.00 |
| Dec 31, 2021 | 65,694.00 |
| Sep 30, 2021 | 60,831.00 |
| Jun 30, 2021 | 88,624.00 |
| Mar 31, 2021 | 71,700.00 |
API Access
Vivos Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RDGL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();